Michael L. Gatza

9.0k total citations
45 papers, 2.6k citations indexed

About

Michael L. Gatza is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael L. Gatza has authored 45 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Michael L. Gatza's work include Cancer Genomics and Diagnostics (8 papers), Bioinformatics and Genomic Networks (7 papers) and Gene expression and cancer classification (6 papers). Michael L. Gatza is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Bioinformatics and Genomic Networks (7 papers) and Gene expression and cancer classification (6 papers). Michael L. Gatza collaborates with scholars based in United States, Türkiye and Japan. Michael L. Gatza's co-authors include Joseph R. Nevins, Charles M. Perou, Susan J. Marriott, Joel S. Parker, Grace O. Silva, Seiichi Mori, Gaurav Mehta, Anil Potti, Huihui Fan and Eran R. Andrechek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Michael L. Gatza

44 papers receiving 2.6k citations

Peers

Countries citing papers authored by Michael L. Gatza

Since Specialization

Citations

This map shows the geographic impact of Michael L. Gatza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Gatza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Gatza more than expected).

Fields of papers citing papers by Michael L. Gatza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Gatza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Gatza. The network helps show where Michael L. Gatza may publish in the future.

Co-authorship network of co-authors of Michael L. Gatza

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Gatza. A scholar is included among the top collaborators of Michael L. Gatza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Gatza. Michael L. Gatza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling 2023 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), (unknown), Karthikeyan Mythreye, Michael L. Gatza	2
2	SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2 2021 ·npj Breast Cancer ·Gaurav Mehta, Steven P. Angus, (unknown), Kevin Tong, Pooja Khanna, Shelley A.H. Dixon, Michael P. Verzi, Gary L. Johnson, Michael L. Gatza	14
3	SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis 2021 ·Oncogene ·Kevin Tong, (unknown), (unknown), Anshuman Panda, (unknown), (unknown), (unknown), Lanjing Zhang, Chang S. Chan, Jinchuan Xing, Michael L. Gatza, Shridar Ganesan, Michael P. Verzi	17
4	Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention 2019 ·Cancer Immunology Research ·Coral Omene, Lin Ma, (unknown), Haoxu Ouyang, Irineu Illa-Bochaca, William Chou, Manan S. Patel, Christopher Sebastiano, Sandra Demaria, Jian‐Hua Mao, Kübra Karagoz, Michael L. Gatza, Mary Helen Barcellos‐Hoff	11
5	SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium 2018 ·Cancer Research ·Ansu O. Perekatt, Pooja Shah, Shannon Cheung, Nidhi Jariwala, (unknown), (unknown), Namit Kumar, Qiang Feng, (unknown), Lei Chen, Shilpy Joshi, Anbo Zhou, (unknown), Jinchuan Xing, Eileen White, Nan Gao, Michael L. Gatza, Michael P. Verzi	57
6	Tumor mutational burden is a determinant of immune-mediated survival in breast cancer 2018 ·OncoImmunology ·Alexandra Thomas, Eric D. Routh, Ashok Pullikuth, Guangxu Jin, Jing Su, Jeff W. Chou, Katherine A. Hoadley, Cristin G. Print, Nicholas Knowlton, Michael A. Black, Sandra Demaria, Ena Wang, Davide Bedognetti, Wendell Jones, Gaurav Mehta, Michael L. Gatza, Charles M. Perou, David B. Page, Pierre L. Triozzi, Lance D. Miller	209
7	The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers 2018 ·Molecular Therapy — Nucleic Acids ·Hamada A. Mokhlis, Recep Bayraktar, Nashwa Kabil, Ayşe Caner, Nermin Kahraman, Cristian Rodriguez‐Aguayo, Érika Pereira Zambalde, Jianting Sheng, Kübra Karagoz, Pınar Kanlikilicer, (unknown), Tamer M. Abdelghany, Ahmed A. Ashour, Stephen T.C. Wong, Michael L. Gatza, George A. Călin, Gabriel Lopez‐Berestein, Bülent Özpolat	28
8	Differentiation among prostate cancer patients with Gleason score of 7 using histopathology image and genomic data 2018 ·PubMed ·Xin Qi, Kübra Karagoz, Jian Ren, David J. Foran, Michael L. Gatza	9
9	Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer 2018 ·Oncogene ·(unknown), (unknown), Alexander A. Chumanevich, (unknown), Jiaxin Liang, Michael L. Gatza, Nam Y. Lee, Igor B. Roninson, Eugenia V. Broude, Karthikeyan Mythreye	48
10	New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging 2017 ·Cancer Research ·Hailey E. Brighton, Steven P. Angus, Tao Bo, Jose Roques, (unknown), David B. Darr, Kübra Karagoz, Noah Sciaky, Michael L. Gatza, Norman E. Sharpless, Gary L. Johnson, James E. Bear	57
11	NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction 2017 ·Cancer Research ·(unknown), Allen L. Alcivar, Jianglin Ma, Tzeh Keong Foo, (unknown), Amar Mahdi, Yanying Huo, Thomas W. Kensler, Michael L. Gatza, Bing Xia	148
12	Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer 2017 ·Breast Cancer Research and Treatment ·Gaurav Mehta, Joel S. Parker, Grace O. Silva, Katherine A. Hoadley, Charles M. Perou, Michael L. Gatza	41
13	Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression 2017 ·Nature Communications ·Juan Liu, Cen Zhang, Yuhan Zhao, Xuetian Yue, Hao Wu, Shan Huang, James Chen, (unknown), Haiyang Xie, (unknown), Michael L. Gatza, Dajing Xia, Jimin Gao, Eileen White, Bruce G. Haffty, Wenwei Hu, Zhaohui Feng	176
14	Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment 2015 ·Oncogene ·Huayu Tian, Jing Liu, (unknown), Michael L. Gatza, Gerard C. Blobe	42
15	Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer 2015 ·Breast Cancer Research and Treatment ·Grace O. Silva, Xiaping He, Joel S. Parker, Michael L. Gatza, Lisa A. Carey, Jack P. Hou, Stacy Moulder, P. Kelly Marcom, Jian Ma, Jeffrey M. Rosen, Charles M. Perou	36
16	FOXO Transcription Factors Control E2F1 Transcriptional Specificity and Apoptotic Function 2013 ·Cancer Research ·Igor Shats, Michael L. Gatza, Beiyu Liu, Steven P. Angus, Lingchong You, Joseph R. Nevins	42
17	Type III TGF-β Receptor Enhances Colon Cancer Cell Migration and Anchorage-Independent Growth 2011 ·Neoplasia ·Catherine E. Gatza, Alisha Holtzhausen, Kellye C. Kirkbride, (unknown), Michael L. Gatza, Michael Datto, Gerard C. Blobe	52
18	Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes 2011 ·Breast Cancer Research ·Michael L. Gatza, Hsiu‐Ni Kung, Kimberly Blackwell, Mark W. Dewhirst, Jeffrey R. Marks, Jen‐Tsan Chi	48
19	Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer 2010 ·Cancer Research ·Igor Shats, Michael L. Gatza, Jeffrey T. Chang, Seiichi Mori, Jialiang Wang, Jeremy N. Rich, Joseph R. Nevins	96
20	A Genomic Strategy to Elucidate Modules of Oncogenic Pathway Signaling Networks 2009 ·Molecular Cell ·Jeffrey T. Chang, Carlos M. Carvalho, Seiichi Mori, Andrea H. Bild, Michael L. Gatza, Quanli Wang, Joseph E. Lucas, Anil Potti, Phillip G. Febbo, Mike West, Joseph R. Nevins	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact